| Application no. and date | 10178515.2 (espacenet) (Federated) (European Patent Register), 20041130 | | Patent/reg. no. and date | DK/EP 2305221, 20150520 | | Publication date | 20110406 | | Priority no. and date | GB 0327844, 20031201, US 526244 P, 20031201 | | EP pub. no. and date |
EP 2305221 20110406 | | Effective date | | | Applicant/owner | The Institute of Cancer Research, 123 Old Brompton Road
London,
Greater London SW7 3RP, GB,
Kudos Pharmaceuticals Limited, 1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge
CB2 0AA, GB | | Applicant ref. no. | P81503345DK00E | | Inventor | Ashworth, Alan, The Breakthrough Breast Cancer Research Centre,
Institute of Cancer Research
123 Old Brompton Road
London, Greater London SW7 3RP, GB,
Jackson, Stephen, c/o AstraZeneca Intellectual Property
AstraZeneca R&D
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB,
Smith, Graeme, AstraZeneca R&D
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB,
Martin, Niall, c/o AstraZeneca Intellectual Property
AstraZeneca R&D
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/502 (2006.01) , A61P 35/00 (2006.01) | | Title | DNA-skadereparationshæmmere til behandling af cancer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
